A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)
Clinical trial NCT02628743 · COMPLETED
Trial details
- NCT number
- NCT02628743
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-20
- Primary completion
- 2018-12-18
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.